Antivirals Market - Global Outlook and Forecast 2022-2028
Antiviral drugs are a class of medication used specifically for treating viral infections rather than bacterial ones. Most antivirals are used for specific viral infections, while a broad-spectrum antiviral is effective against a wide range of viruses. Unlike most antibiotics, antiviral drugs do not destroy their target pathogen; instead they inhibit their development.
This report contains market size and forecasts of Antivirals in global, including the following market information:
Global Antivirals Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Antivirals Market Sales, 2017-2022, 2023-2028, (K MT)
Global top five Antivirals companies in 2021 (%)
The global Antivirals market was valued at 45910 million in 2021 and is projected to reach US$ 61670 million by 2028, at a CAGR of 4.3% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Generic Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Antivirals include Merck, Johnson & Johnson, Teva Pharmaceutical Industries, GSK, Mylan, Gilead Sciences, F. Hoffmann-La Roche, Bristol-Myers-Squibb and AbbVie, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Antivirals manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Antivirals Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Antivirals Market Segment Percentages, by Type, 2021 (%)
Global Antivirals Market Segment Percentages, by Application, 2021 (%)
Global Antivirals Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Antivirals revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Antivirals revenues share in global market, 2021 (%)
Key companies Antivirals sales in global market, 2017-2022 (Estimated), (K MT)
Key companies Antivirals sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Antivirals in global, including the following market information:
Global Antivirals Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Antivirals Market Sales, 2017-2022, 2023-2028, (K MT)
Global top five Antivirals companies in 2021 (%)
The global Antivirals market was valued at 45910 million in 2021 and is projected to reach US$ 61670 million by 2028, at a CAGR of 4.3% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Generic Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Antivirals include Merck, Johnson & Johnson, Teva Pharmaceutical Industries, GSK, Mylan, Gilead Sciences, F. Hoffmann-La Roche, Bristol-Myers-Squibb and AbbVie, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Antivirals manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Antivirals Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Antivirals Market Segment Percentages, by Type, 2021 (%)
- Generic
- Branded
Global Antivirals Market Segment Percentages, by Application, 2021 (%)
- HIV
- Hepatitis
- HSV
- Influenza
Global Antivirals Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Antivirals revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Antivirals revenues share in global market, 2021 (%)
Key companies Antivirals sales in global market, 2017-2022 (Estimated), (K MT)
Key companies Antivirals sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Merck
- Johnson & Johnson
- Teva Pharmaceutical Industries
- GSK
- Mylan
- Gilead Sciences
- F. Hoffmann-La Roche
- Bristol-Myers-Squibb
- AbbVie
- Aurobindo Pharma
- Cipla
- Dr Reddy’s
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Antivirals Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Antivirals Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL ANTIVIRALS OVERALL MARKET SIZE
2.1 Global Antivirals Market Size: 2021 VS 2028
2.2 Global Antivirals Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Antivirals Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Antivirals Players in Global Market
3.2 Top Global Antivirals Companies Ranked by Revenue
3.3 Global Antivirals Revenue by Companies
3.4 Global Antivirals Sales by Companies
3.5 Global Antivirals Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Antivirals Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Antivirals Product Type
3.8 Tier 1, Tier 2 and Tier 3 Antivirals Players in Global Market
3.8.1 List of Global Tier 1 Antivirals Companies
3.8.2 List of Global Tier 2 and Tier 3 Antivirals Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Antivirals Market Size Markets, 2021 & 2028
4.1.2 Generic
4.1.3 Branded
4.2 By Type - Global Antivirals Revenue & Forecasts
4.2.1 By Type - Global Antivirals Revenue, 2017-2022
4.2.2 By Type - Global Antivirals Revenue, 2023-2028
4.2.3 By Type - Global Antivirals Revenue Market Share, 2017-2028
4.3 By Type - Global Antivirals Sales & Forecasts
4.3.1 By Type - Global Antivirals Sales, 2017-2022
4.3.2 By Type - Global Antivirals Sales, 2023-2028
4.3.3 By Type - Global Antivirals Sales Market Share, 2017-2028
4.4 By Type - Global Antivirals Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Antivirals Market Size, 2021 & 2028
5.1.2 HIV
5.1.3 Hepatitis
5.1.4 HSV
5.1.5 Influenza
5.2 By Application - Global Antivirals Revenue & Forecasts
5.2.1 By Application - Global Antivirals Revenue, 2017-2022
5.2.2 By Application - Global Antivirals Revenue, 2023-2028
5.2.3 By Application - Global Antivirals Revenue Market Share, 2017-2028
5.3 By Application - Global Antivirals Sales & Forecasts
5.3.1 By Application - Global Antivirals Sales, 2017-2022
5.3.2 By Application - Global Antivirals Sales, 2023-2028
5.3.3 By Application - Global Antivirals Sales Market Share, 2017-2028
5.4 By Application - Global Antivirals Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Antivirals Market Size, 2021 & 2028
6.2 By Region - Global Antivirals Revenue & Forecasts
6.2.1 By Region - Global Antivirals Revenue, 2017-2022
6.2.2 By Region - Global Antivirals Revenue, 2023-2028
6.2.3 By Region - Global Antivirals Revenue Market Share, 2017-2028
6.3 By Region - Global Antivirals Sales & Forecasts
6.3.1 By Region - Global Antivirals Sales, 2017-2022
6.3.2 By Region - Global Antivirals Sales, 2023-2028
6.3.3 By Region - Global Antivirals Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Antivirals Revenue, 2017-2028
6.4.2 By Country - North America Antivirals Sales, 2017-2028
6.4.3 US Antivirals Market Size, 2017-2028
6.4.4 Canada Antivirals Market Size, 2017-2028
6.4.5 Mexico Antivirals Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Antivirals Revenue, 2017-2028
6.5.2 By Country - Europe Antivirals Sales, 2017-2028
6.5.3 Germany Antivirals Market Size, 2017-2028
6.5.4 France Antivirals Market Size, 2017-2028
6.5.5 U.K. Antivirals Market Size, 2017-2028
6.5.6 Italy Antivirals Market Size, 2017-2028
6.5.7 Russia Antivirals Market Size, 2017-2028
6.5.8 Nordic Countries Antivirals Market Size, 2017-2028
6.5.9 Benelux Antivirals Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Antivirals Revenue, 2017-2028
6.6.2 By Region - Asia Antivirals Sales, 2017-2028
6.6.3 China Antivirals Market Size, 2017-2028
6.6.4 Japan Antivirals Market Size, 2017-2028
6.6.5 South Korea Antivirals Market Size, 2017-2028
6.6.6 Southeast Asia Antivirals Market Size, 2017-2028
6.6.7 India Antivirals Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Antivirals Revenue, 2017-2028
6.7.2 By Country - South America Antivirals Sales, 2017-2028
6.7.3 Brazil Antivirals Market Size, 2017-2028
6.7.4 Argentina Antivirals Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Antivirals Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Antivirals Sales, 2017-2028
6.8.3 Turkey Antivirals Market Size, 2017-2028
6.8.4 Israel Antivirals Market Size, 2017-2028
6.8.5 Saudi Arabia Antivirals Market Size, 2017-2028
6.8.6 UAE Antivirals Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Merck
7.1.1 Merck Corporate Summary
7.1.2 Merck Business Overview
7.1.3 Merck Antivirals Major Product Offerings
7.1.4 Merck Antivirals Sales and Revenue in Global (2017-2022)
7.1.5 Merck Key News
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Corporate Summary
7.2.2 Johnson & Johnson Business Overview
7.2.3 Johnson & Johnson Antivirals Major Product Offerings
7.2.4 Johnson & Johnson Antivirals Sales and Revenue in Global (2017-2022)
7.2.5 Johnson & Johnson Key News
7.3 Teva Pharmaceutical Industries
7.3.1 Teva Pharmaceutical Industries Corporate Summary
7.3.2 Teva Pharmaceutical Industries Business Overview
7.3.3 Teva Pharmaceutical Industries Antivirals Major Product Offerings
7.3.4 Teva Pharmaceutical Industries Antivirals Sales and Revenue in Global (2017-2022)
7.3.5 Teva Pharmaceutical Industries Key News
7.4 GSK
7.4.1 GSK Corporate Summary
7.4.2 GSK Business Overview
7.4.3 GSK Antivirals Major Product Offerings
7.4.4 GSK Antivirals Sales and Revenue in Global (2017-2022)
7.4.5 GSK Key News
7.5 Mylan
7.5.1 Mylan Corporate Summary
7.5.2 Mylan Business Overview
7.5.3 Mylan Antivirals Major Product Offerings
7.5.4 Mylan Antivirals Sales and Revenue in Global (2017-2022)
7.5.5 Mylan Key News
7.6 Gilead Sciences
7.6.1 Gilead Sciences Corporate Summary
7.6.2 Gilead Sciences Business Overview
7.6.3 Gilead Sciences Antivirals Major Product Offerings
7.6.4 Gilead Sciences Antivirals Sales and Revenue in Global (2017-2022)
7.6.5 Gilead Sciences Key News
7.7 F. Hoffmann-La Roche
7.7.1 F. Hoffmann-La Roche Corporate Summary
7.7.2 F. Hoffmann-La Roche Business Overview
7.7.3 F. Hoffmann-La Roche Antivirals Major Product Offerings
7.7.4 F. Hoffmann-La Roche Antivirals Sales and Revenue in Global (2017-2022)
7.7.5 F. Hoffmann-La Roche Key News
7.8 Bristol-Myers-Squibb
7.8.1 Bristol-Myers-Squibb Corporate Summary
7.8.2 Bristol-Myers-Squibb Business Overview
7.8.3 Bristol-Myers-Squibb Antivirals Major Product Offerings
7.8.4 Bristol-Myers-Squibb Antivirals Sales and Revenue in Global (2017-2022)
7.8.5 Bristol-Myers-Squibb Key News
7.9 AbbVie
7.9.1 AbbVie Corporate Summary
7.9.2 AbbVie Business Overview
7.9.3 AbbVie Antivirals Major Product Offerings
7.9.4 AbbVie Antivirals Sales and Revenue in Global (2017-2022)
7.9.5 AbbVie Key News
7.10 Aurobindo Pharma
7.10.1 Aurobindo Pharma Corporate Summary
7.10.2 Aurobindo Pharma Business Overview
7.10.3 Aurobindo Pharma Antivirals Major Product Offerings
7.10.4 Aurobindo Pharma Antivirals Sales and Revenue in Global (2017-2022)
7.10.5 Aurobindo Pharma Key News
7.11 Cipla
7.11.1 Cipla Corporate Summary
7.11.2 Cipla Antivirals Business Overview
7.11.3 Cipla Antivirals Major Product Offerings
7.11.4 Cipla Antivirals Sales and Revenue in Global (2017-2022)
7.11.5 Cipla Key News
7.12 Dr Reddy’s
7.12.1 Dr Reddy’s Corporate Summary
7.12.2 Dr Reddy’s Antivirals Business Overview
7.12.3 Dr Reddy’s Antivirals Major Product Offerings
7.12.4 Dr Reddy’s Antivirals Sales and Revenue in Global (2017-2022)
7.12.5 Dr Reddy’s Key News
8 GLOBAL ANTIVIRALS PRODUCTION CAPACITY, ANALYSIS
8.1 Global Antivirals Production Capacity, 2017-2028
8.2 Antivirals Production Capacity of Key Manufacturers in Global Market
8.3 Global Antivirals Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 ANTIVIRALS SUPPLY CHAIN ANALYSIS
10.1 Antivirals Industry Value Chain
10.2 Antivirals Upstream Market
10.3 Antivirals Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Antivirals Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Antivirals Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Antivirals Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL ANTIVIRALS OVERALL MARKET SIZE
2.1 Global Antivirals Market Size: 2021 VS 2028
2.2 Global Antivirals Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Antivirals Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Antivirals Players in Global Market
3.2 Top Global Antivirals Companies Ranked by Revenue
3.3 Global Antivirals Revenue by Companies
3.4 Global Antivirals Sales by Companies
3.5 Global Antivirals Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Antivirals Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Antivirals Product Type
3.8 Tier 1, Tier 2 and Tier 3 Antivirals Players in Global Market
3.8.1 List of Global Tier 1 Antivirals Companies
3.8.2 List of Global Tier 2 and Tier 3 Antivirals Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Antivirals Market Size Markets, 2021 & 2028
4.1.2 Generic
4.1.3 Branded
4.2 By Type - Global Antivirals Revenue & Forecasts
4.2.1 By Type - Global Antivirals Revenue, 2017-2022
4.2.2 By Type - Global Antivirals Revenue, 2023-2028
4.2.3 By Type - Global Antivirals Revenue Market Share, 2017-2028
4.3 By Type - Global Antivirals Sales & Forecasts
4.3.1 By Type - Global Antivirals Sales, 2017-2022
4.3.2 By Type - Global Antivirals Sales, 2023-2028
4.3.3 By Type - Global Antivirals Sales Market Share, 2017-2028
4.4 By Type - Global Antivirals Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Antivirals Market Size, 2021 & 2028
5.1.2 HIV
5.1.3 Hepatitis
5.1.4 HSV
5.1.5 Influenza
5.2 By Application - Global Antivirals Revenue & Forecasts
5.2.1 By Application - Global Antivirals Revenue, 2017-2022
5.2.2 By Application - Global Antivirals Revenue, 2023-2028
5.2.3 By Application - Global Antivirals Revenue Market Share, 2017-2028
5.3 By Application - Global Antivirals Sales & Forecasts
5.3.1 By Application - Global Antivirals Sales, 2017-2022
5.3.2 By Application - Global Antivirals Sales, 2023-2028
5.3.3 By Application - Global Antivirals Sales Market Share, 2017-2028
5.4 By Application - Global Antivirals Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Antivirals Market Size, 2021 & 2028
6.2 By Region - Global Antivirals Revenue & Forecasts
6.2.1 By Region - Global Antivirals Revenue, 2017-2022
6.2.2 By Region - Global Antivirals Revenue, 2023-2028
6.2.3 By Region - Global Antivirals Revenue Market Share, 2017-2028
6.3 By Region - Global Antivirals Sales & Forecasts
6.3.1 By Region - Global Antivirals Sales, 2017-2022
6.3.2 By Region - Global Antivirals Sales, 2023-2028
6.3.3 By Region - Global Antivirals Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Antivirals Revenue, 2017-2028
6.4.2 By Country - North America Antivirals Sales, 2017-2028
6.4.3 US Antivirals Market Size, 2017-2028
6.4.4 Canada Antivirals Market Size, 2017-2028
6.4.5 Mexico Antivirals Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Antivirals Revenue, 2017-2028
6.5.2 By Country - Europe Antivirals Sales, 2017-2028
6.5.3 Germany Antivirals Market Size, 2017-2028
6.5.4 France Antivirals Market Size, 2017-2028
6.5.5 U.K. Antivirals Market Size, 2017-2028
6.5.6 Italy Antivirals Market Size, 2017-2028
6.5.7 Russia Antivirals Market Size, 2017-2028
6.5.8 Nordic Countries Antivirals Market Size, 2017-2028
6.5.9 Benelux Antivirals Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Antivirals Revenue, 2017-2028
6.6.2 By Region - Asia Antivirals Sales, 2017-2028
6.6.3 China Antivirals Market Size, 2017-2028
6.6.4 Japan Antivirals Market Size, 2017-2028
6.6.5 South Korea Antivirals Market Size, 2017-2028
6.6.6 Southeast Asia Antivirals Market Size, 2017-2028
6.6.7 India Antivirals Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Antivirals Revenue, 2017-2028
6.7.2 By Country - South America Antivirals Sales, 2017-2028
6.7.3 Brazil Antivirals Market Size, 2017-2028
6.7.4 Argentina Antivirals Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Antivirals Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Antivirals Sales, 2017-2028
6.8.3 Turkey Antivirals Market Size, 2017-2028
6.8.4 Israel Antivirals Market Size, 2017-2028
6.8.5 Saudi Arabia Antivirals Market Size, 2017-2028
6.8.6 UAE Antivirals Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Merck
7.1.1 Merck Corporate Summary
7.1.2 Merck Business Overview
7.1.3 Merck Antivirals Major Product Offerings
7.1.4 Merck Antivirals Sales and Revenue in Global (2017-2022)
7.1.5 Merck Key News
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Corporate Summary
7.2.2 Johnson & Johnson Business Overview
7.2.3 Johnson & Johnson Antivirals Major Product Offerings
7.2.4 Johnson & Johnson Antivirals Sales and Revenue in Global (2017-2022)
7.2.5 Johnson & Johnson Key News
7.3 Teva Pharmaceutical Industries
7.3.1 Teva Pharmaceutical Industries Corporate Summary
7.3.2 Teva Pharmaceutical Industries Business Overview
7.3.3 Teva Pharmaceutical Industries Antivirals Major Product Offerings
7.3.4 Teva Pharmaceutical Industries Antivirals Sales and Revenue in Global (2017-2022)
7.3.5 Teva Pharmaceutical Industries Key News
7.4 GSK
7.4.1 GSK Corporate Summary
7.4.2 GSK Business Overview
7.4.3 GSK Antivirals Major Product Offerings
7.4.4 GSK Antivirals Sales and Revenue in Global (2017-2022)
7.4.5 GSK Key News
7.5 Mylan
7.5.1 Mylan Corporate Summary
7.5.2 Mylan Business Overview
7.5.3 Mylan Antivirals Major Product Offerings
7.5.4 Mylan Antivirals Sales and Revenue in Global (2017-2022)
7.5.5 Mylan Key News
7.6 Gilead Sciences
7.6.1 Gilead Sciences Corporate Summary
7.6.2 Gilead Sciences Business Overview
7.6.3 Gilead Sciences Antivirals Major Product Offerings
7.6.4 Gilead Sciences Antivirals Sales and Revenue in Global (2017-2022)
7.6.5 Gilead Sciences Key News
7.7 F. Hoffmann-La Roche
7.7.1 F. Hoffmann-La Roche Corporate Summary
7.7.2 F. Hoffmann-La Roche Business Overview
7.7.3 F. Hoffmann-La Roche Antivirals Major Product Offerings
7.7.4 F. Hoffmann-La Roche Antivirals Sales and Revenue in Global (2017-2022)
7.7.5 F. Hoffmann-La Roche Key News
7.8 Bristol-Myers-Squibb
7.8.1 Bristol-Myers-Squibb Corporate Summary
7.8.2 Bristol-Myers-Squibb Business Overview
7.8.3 Bristol-Myers-Squibb Antivirals Major Product Offerings
7.8.4 Bristol-Myers-Squibb Antivirals Sales and Revenue in Global (2017-2022)
7.8.5 Bristol-Myers-Squibb Key News
7.9 AbbVie
7.9.1 AbbVie Corporate Summary
7.9.2 AbbVie Business Overview
7.9.3 AbbVie Antivirals Major Product Offerings
7.9.4 AbbVie Antivirals Sales and Revenue in Global (2017-2022)
7.9.5 AbbVie Key News
7.10 Aurobindo Pharma
7.10.1 Aurobindo Pharma Corporate Summary
7.10.2 Aurobindo Pharma Business Overview
7.10.3 Aurobindo Pharma Antivirals Major Product Offerings
7.10.4 Aurobindo Pharma Antivirals Sales and Revenue in Global (2017-2022)
7.10.5 Aurobindo Pharma Key News
7.11 Cipla
7.11.1 Cipla Corporate Summary
7.11.2 Cipla Antivirals Business Overview
7.11.3 Cipla Antivirals Major Product Offerings
7.11.4 Cipla Antivirals Sales and Revenue in Global (2017-2022)
7.11.5 Cipla Key News
7.12 Dr Reddy’s
7.12.1 Dr Reddy’s Corporate Summary
7.12.2 Dr Reddy’s Antivirals Business Overview
7.12.3 Dr Reddy’s Antivirals Major Product Offerings
7.12.4 Dr Reddy’s Antivirals Sales and Revenue in Global (2017-2022)
7.12.5 Dr Reddy’s Key News
8 GLOBAL ANTIVIRALS PRODUCTION CAPACITY, ANALYSIS
8.1 Global Antivirals Production Capacity, 2017-2028
8.2 Antivirals Production Capacity of Key Manufacturers in Global Market
8.3 Global Antivirals Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 ANTIVIRALS SUPPLY CHAIN ANALYSIS
10.1 Antivirals Industry Value Chain
10.2 Antivirals Upstream Market
10.3 Antivirals Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Antivirals Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Antivirals in Global Market
Table 2. Top Antivirals Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Antivirals Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Antivirals Revenue Share by Companies, 2017-2022
Table 5. Global Antivirals Sales by Companies, (K MT), 2017-2022
Table 6. Global Antivirals Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Antivirals Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Antivirals Product Type
Table 9. List of Global Tier 1 Antivirals Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Antivirals Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Antivirals Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Antivirals Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Antivirals Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Antivirals Sales (K MT), 2017-2022
Table 15. By Type - Global Antivirals Sales (K MT), 2023-2028
Table 16. By Application – Global Antivirals Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Antivirals Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Antivirals Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Antivirals Sales (K MT), 2017-2022
Table 20. By Application - Global Antivirals Sales (K MT), 2023-2028
Table 21. By Region – Global Antivirals Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Antivirals Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Antivirals Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Antivirals Sales (K MT), 2017-2022
Table 25. By Region - Global Antivirals Sales (K MT), 2023-2028
Table 26. By Country - North America Antivirals Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Antivirals Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Antivirals Sales, (K MT), 2017-2022
Table 29. By Country - North America Antivirals Sales, (K MT), 2023-2028
Table 30. By Country - Europe Antivirals Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Antivirals Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Antivirals Sales, (K MT), 2017-2022
Table 33. By Country - Europe Antivirals Sales, (K MT), 2023-2028
Table 34. By Region - Asia Antivirals Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Antivirals Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Antivirals Sales, (K MT), 2017-2022
Table 37. By Region - Asia Antivirals Sales, (K MT), 2023-2028
Table 38. By Country - South America Antivirals Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Antivirals Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Antivirals Sales, (K MT), 2017-2022
Table 41. By Country - South America Antivirals Sales, (K MT), 2023-2028
Table 42. By Country - Middle East & Africa Antivirals Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Antivirals Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Antivirals Sales, (K MT), 2017-2022
Table 45. By Country - Middle East & Africa Antivirals Sales, (K MT), 2023-2028
Table 46. Merck Corporate Summary
Table 47. Merck Antivirals Product Offerings
Table 48. Merck Antivirals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Johnson & Johnson Corporate Summary
Table 50. Johnson & Johnson Antivirals Product Offerings
Table 51. Johnson & Johnson Antivirals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Teva Pharmaceutical Industries Corporate Summary
Table 53. Teva Pharmaceutical Industries Antivirals Product Offerings
Table 54. Teva Pharmaceutical Industries Antivirals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. GSK Corporate Summary
Table 56. GSK Antivirals Product Offerings
Table 57. GSK Antivirals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. Mylan Corporate Summary
Table 59. Mylan Antivirals Product Offerings
Table 60. Mylan Antivirals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. Gilead Sciences Corporate Summary
Table 62. Gilead Sciences Antivirals Product Offerings
Table 63. Gilead Sciences Antivirals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. F. Hoffmann-La Roche Corporate Summary
Table 65. F. Hoffmann-La Roche Antivirals Product Offerings
Table 66. F. Hoffmann-La Roche Antivirals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 67. Bristol-Myers-Squibb Corporate Summary
Table 68. Bristol-Myers-Squibb Antivirals Product Offerings
Table 69. Bristol-Myers-Squibb Antivirals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 70. AbbVie Corporate Summary
Table 71. AbbVie Antivirals Product Offerings
Table 72. AbbVie Antivirals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 73. Aurobindo Pharma Corporate Summary
Table 74. Aurobindo Pharma Antivirals Product Offerings
Table 75. Aurobindo Pharma Antivirals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 76. Cipla Corporate Summary
Table 77. Cipla Antivirals Product Offerings
Table 78. Cipla Antivirals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 79. Dr Reddy’s Corporate Summary
Table 80. Dr Reddy’s Antivirals Product Offerings
Table 81. Dr Reddy’s Antivirals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 82. Antivirals Production Capacity (K MT) of Key Manufacturers in Global Market, 2020-2022 (K MT)
Table 83. Global Antivirals Capacity Market Share of Key Manufacturers, 2020-2022
Table 84. Global Antivirals Production by Region, 2017-2022 (K MT)
Table 85. Global Antivirals Production by Region, 2023-2028 (K MT)
Table 86. Antivirals Market Opportunities & Trends in Global Market
Table 87. Antivirals Market Drivers in Global Market
Table 88. Antivirals Market Restraints in Global Market
Table 89. Antivirals Raw Materials
Table 90. Antivirals Raw Materials Suppliers in Global Market
Table 91. Typical Antivirals Downstream
Table 92. Antivirals Downstream Clients in Global Market
Table 93. Antivirals Distributors and Sales Agents in Global Market
Table 1. Key Players of Antivirals in Global Market
Table 2. Top Antivirals Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Antivirals Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Antivirals Revenue Share by Companies, 2017-2022
Table 5. Global Antivirals Sales by Companies, (K MT), 2017-2022
Table 6. Global Antivirals Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Antivirals Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Antivirals Product Type
Table 9. List of Global Tier 1 Antivirals Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Antivirals Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Antivirals Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Antivirals Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Antivirals Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Antivirals Sales (K MT), 2017-2022
Table 15. By Type - Global Antivirals Sales (K MT), 2023-2028
Table 16. By Application – Global Antivirals Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Antivirals Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Antivirals Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Antivirals Sales (K MT), 2017-2022
Table 20. By Application - Global Antivirals Sales (K MT), 2023-2028
Table 21. By Region – Global Antivirals Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Antivirals Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Antivirals Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Antivirals Sales (K MT), 2017-2022
Table 25. By Region - Global Antivirals Sales (K MT), 2023-2028
Table 26. By Country - North America Antivirals Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Antivirals Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Antivirals Sales, (K MT), 2017-2022
Table 29. By Country - North America Antivirals Sales, (K MT), 2023-2028
Table 30. By Country - Europe Antivirals Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Antivirals Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Antivirals Sales, (K MT), 2017-2022
Table 33. By Country - Europe Antivirals Sales, (K MT), 2023-2028
Table 34. By Region - Asia Antivirals Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Antivirals Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Antivirals Sales, (K MT), 2017-2022
Table 37. By Region - Asia Antivirals Sales, (K MT), 2023-2028
Table 38. By Country - South America Antivirals Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Antivirals Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Antivirals Sales, (K MT), 2017-2022
Table 41. By Country - South America Antivirals Sales, (K MT), 2023-2028
Table 42. By Country - Middle East & Africa Antivirals Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Antivirals Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Antivirals Sales, (K MT), 2017-2022
Table 45. By Country - Middle East & Africa Antivirals Sales, (K MT), 2023-2028
Table 46. Merck Corporate Summary
Table 47. Merck Antivirals Product Offerings
Table 48. Merck Antivirals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Johnson & Johnson Corporate Summary
Table 50. Johnson & Johnson Antivirals Product Offerings
Table 51. Johnson & Johnson Antivirals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Teva Pharmaceutical Industries Corporate Summary
Table 53. Teva Pharmaceutical Industries Antivirals Product Offerings
Table 54. Teva Pharmaceutical Industries Antivirals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. GSK Corporate Summary
Table 56. GSK Antivirals Product Offerings
Table 57. GSK Antivirals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. Mylan Corporate Summary
Table 59. Mylan Antivirals Product Offerings
Table 60. Mylan Antivirals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. Gilead Sciences Corporate Summary
Table 62. Gilead Sciences Antivirals Product Offerings
Table 63. Gilead Sciences Antivirals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. F. Hoffmann-La Roche Corporate Summary
Table 65. F. Hoffmann-La Roche Antivirals Product Offerings
Table 66. F. Hoffmann-La Roche Antivirals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 67. Bristol-Myers-Squibb Corporate Summary
Table 68. Bristol-Myers-Squibb Antivirals Product Offerings
Table 69. Bristol-Myers-Squibb Antivirals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 70. AbbVie Corporate Summary
Table 71. AbbVie Antivirals Product Offerings
Table 72. AbbVie Antivirals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 73. Aurobindo Pharma Corporate Summary
Table 74. Aurobindo Pharma Antivirals Product Offerings
Table 75. Aurobindo Pharma Antivirals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 76. Cipla Corporate Summary
Table 77. Cipla Antivirals Product Offerings
Table 78. Cipla Antivirals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 79. Dr Reddy’s Corporate Summary
Table 80. Dr Reddy’s Antivirals Product Offerings
Table 81. Dr Reddy’s Antivirals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 82. Antivirals Production Capacity (K MT) of Key Manufacturers in Global Market, 2020-2022 (K MT)
Table 83. Global Antivirals Capacity Market Share of Key Manufacturers, 2020-2022
Table 84. Global Antivirals Production by Region, 2017-2022 (K MT)
Table 85. Global Antivirals Production by Region, 2023-2028 (K MT)
Table 86. Antivirals Market Opportunities & Trends in Global Market
Table 87. Antivirals Market Drivers in Global Market
Table 88. Antivirals Market Restraints in Global Market
Table 89. Antivirals Raw Materials
Table 90. Antivirals Raw Materials Suppliers in Global Market
Table 91. Typical Antivirals Downstream
Table 92. Antivirals Downstream Clients in Global Market
Table 93. Antivirals Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Antivirals Segment by Type
Figure 2. Antivirals Segment by Application
Figure 3. Global Antivirals Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Antivirals Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Antivirals Revenue, 2017-2028 (US$, Mn)
Figure 7. Antivirals Sales in Global Market: 2017-2028 (K MT)
Figure 8. The Top 3 and 5 Players Market Share by Antivirals Revenue in 2021
Figure 9. By Type - Global Antivirals Sales Market Share, 2017-2028
Figure 10. By Type - Global Antivirals Revenue Market Share, 2017-2028
Figure 11. By Type - Global Antivirals Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Antivirals Sales Market Share, 2017-2028
Figure 13. By Application - Global Antivirals Revenue Market Share, 2017-2028
Figure 14. By Application - Global Antivirals Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Antivirals Sales Market Share, 2017-2028
Figure 16. By Region - Global Antivirals Revenue Market Share, 2017-2028
Figure 17. By Country - North America Antivirals Revenue Market Share, 2017-2028
Figure 18. By Country - North America Antivirals Sales Market Share, 2017-2028
Figure 19. US Antivirals Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Antivirals Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Antivirals Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Antivirals Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Antivirals Sales Market Share, 2017-2028
Figure 24. Germany Antivirals Revenue, (US$, Mn), 2017-2028
Figure 25. France Antivirals Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Antivirals Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Antivirals Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Antivirals Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Antivirals Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Antivirals Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Antivirals Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Antivirals Sales Market Share, 2017-2028
Figure 33. China Antivirals Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Antivirals Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Antivirals Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Antivirals Revenue, (US$, Mn), 2017-2028
Figure 37. India Antivirals Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Antivirals Revenue Market Share, 2017-2028
Figure 39. By Country - South America Antivirals Sales Market Share, 2017-2028
Figure 40. Brazil Antivirals Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Antivirals Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Antivirals Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Antivirals Sales Market Share, 2017-2028
Figure 44. Turkey Antivirals Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Antivirals Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Antivirals Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Antivirals Revenue, (US$, Mn), 2017-2028
Figure 48. Global Antivirals Production Capacity (K MT), 2017-2028
Figure 49. The Percentage of Production Antivirals by Region, 2020 VS 2027
Figure 50. Antivirals Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Antivirals Segment by Type
Figure 2. Antivirals Segment by Application
Figure 3. Global Antivirals Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Antivirals Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Antivirals Revenue, 2017-2028 (US$, Mn)
Figure 7. Antivirals Sales in Global Market: 2017-2028 (K MT)
Figure 8. The Top 3 and 5 Players Market Share by Antivirals Revenue in 2021
Figure 9. By Type - Global Antivirals Sales Market Share, 2017-2028
Figure 10. By Type - Global Antivirals Revenue Market Share, 2017-2028
Figure 11. By Type - Global Antivirals Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Antivirals Sales Market Share, 2017-2028
Figure 13. By Application - Global Antivirals Revenue Market Share, 2017-2028
Figure 14. By Application - Global Antivirals Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Antivirals Sales Market Share, 2017-2028
Figure 16. By Region - Global Antivirals Revenue Market Share, 2017-2028
Figure 17. By Country - North America Antivirals Revenue Market Share, 2017-2028
Figure 18. By Country - North America Antivirals Sales Market Share, 2017-2028
Figure 19. US Antivirals Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Antivirals Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Antivirals Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Antivirals Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Antivirals Sales Market Share, 2017-2028
Figure 24. Germany Antivirals Revenue, (US$, Mn), 2017-2028
Figure 25. France Antivirals Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Antivirals Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Antivirals Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Antivirals Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Antivirals Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Antivirals Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Antivirals Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Antivirals Sales Market Share, 2017-2028
Figure 33. China Antivirals Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Antivirals Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Antivirals Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Antivirals Revenue, (US$, Mn), 2017-2028
Figure 37. India Antivirals Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Antivirals Revenue Market Share, 2017-2028
Figure 39. By Country - South America Antivirals Sales Market Share, 2017-2028
Figure 40. Brazil Antivirals Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Antivirals Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Antivirals Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Antivirals Sales Market Share, 2017-2028
Figure 44. Turkey Antivirals Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Antivirals Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Antivirals Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Antivirals Revenue, (US$, Mn), 2017-2028
Figure 48. Global Antivirals Production Capacity (K MT), 2017-2028
Figure 49. The Percentage of Production Antivirals by Region, 2020 VS 2027
Figure 50. Antivirals Industry Value Chain
Figure 51. Marketing Channels
